RAPTOR RESOURCES LIMITED - Announcements

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 # Add to my watchlist

ResApp Health Limited is an Australia-based digital health company engaged in developing... ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers. The Company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. Its products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Its obstructive sleep aponia screening test uses overnight breathing and snoring sounds recorded on a smartphone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAP	Removal from Official List		27/09/22	404.27KB	Share
RAP	Scheme of Arrangement has been Implemented	PRICE SENSITIVE	26/09/22	55.41KB	Share
RAP	Ceasing to be a substantial holder		20/09/22	58.53KB	Share
RAP	Becoming a substantial holder		19/09/22	210.88KB	Share
RAP	Notification of cessation of securities - RAP		16/09/22	31.71KB	Share
RAP	Ceasing to be a substantial holder		16/09/22	80.15KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	15/09/22	591.98KB	Share
RAP	Scheme of Arrangement becomes effective	PRICE SENSITIVE	15/09/22	130.98KB	Share
RAP	Scheme of Arrangement - Court Approval	PRICE SENSITIVE	14/09/22	89.15KB	Share
RAP	Becoming a substantial holder		08/09/22	175.85KB	Share
RAP	Results of Scheme Meeting	PRICE SENSITIVE	07/09/22	185.86KB	Share
RAP	Scheme Meeting - Chairman's Address & Presentation	PRICE SENSITIVE	07/09/22	2.89MB	Share
RAP	Becoming a substantial holder		05/09/22	310.91KB	Share
RAP	Appendix 4G		30/08/22	283.58KB	Share
RAP	Corporate Governance Statement		30/08/22	114.04KB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	30/08/22	2.18MB	Share
RAP	Dispatch of Second Supplementary Scheme Booklet		29/08/22	124.05KB	Share
RAP	Second Supplementary Scheme Booklet	PRICE SENSITIVE	25/08/22	918.11KB	Share
RAP	Correction to ASX announcement		19/08/22	68.02KB	Share
RAP	Adjournment of Scheme Meeting to a date to be determined	PRICE SENSITIVE	19/08/22	66.64KB	Share
RAP	Best and Final Confirmation and Bridging Loan	PRICE SENSITIVE	16/08/22	489.09KB	Share
RAP	Dispatch of Supplementary Scheme Booklet		08/08/22	135.55KB	Share
RAP	Pfizer raises scheme consideration to A$0.208 per share	PRICE SENSITIVE	05/08/22	473.41KB	Share
RAP	Correction to ASX announcement		03/08/22	87.02KB	Share
RAP	Entry into amended and restated Scheme Implementation Deed	PRICE SENSITIVE	03/08/22	975.99KB	Share
RAP	Investor Conference Call Notification		02/08/22	90.87KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/07/22	1.2MB	Share
RAP	Quarterly Results and Investor Conference Call Notification		25/07/22	88.58KB	Share
RAP	Study shows efficacy of ResAppDx use with masks		22/07/22	101.02KB	Share
RAP	Dispatch of Scheme Booklet		20/07/22	130.58KB	Share
RAP	Clarification - Scheme Booklet registered with ASIC		20/07/22	127.96KB	Share
RAP	Scheme Update - ACCC condition precedent satisfied	PRICE SENSITIVE	18/07/22	95.44KB	Share
RAP	Scheme Booklet registered with ASIC	PRICE SENSITIVE	18/07/22	4.14MB	Share
RAP	Results of First Court Hearing	PRICE SENSITIVE	15/07/22	131.07KB	Share
RAP	Medgate Licence Agreement Clarification Announcement		11/07/22	87.61KB	Share
RAP	Medgate extends licence agreement and plans to expand use	PRICE SENSITIVE	07/07/22	107.19KB	Share
RAP	ResApp receives FDA 510(k) clearance for SleepCheckRx	PRICE SENSITIVE	06/07/22	106.06KB	Share
RAP	Cough detection patent granted in Australia and Japan		05/07/22	88.02KB	Share
RAP	Scheme Update		30/06/22	83.82KB	Share
RAP	ResApp to present at Gold Coast Investment Showcase		23/06/22	87.84KB	Share
RAP	Results from Data Confirmation Study	PRICE SENSITIVE	21/06/22	112.24KB	Share
RAP	Trading Halt	PRICE SENSITIVE	20/06/22	675.51KB	Share
RAP	Investor Webinar		17/06/22	87.97KB	Share
RAP	Notification of cessation of securities - RAP		16/06/22	21.76KB	Share
RAP	Application for quotation of securities - RAP		16/06/22	25KB	Share
RAP	Notification of cessation of securities - RAP		14/06/22	22.12KB	Share
RAP	Reinstatement to Official Quotation	PRICE SENSITIVE	14/06/22	410.87KB	Share
RAP	Increased Scheme Consideration from Pfizer	PRICE SENSITIVE	14/06/22	833.75KB	Share
RAP	Voluntary Suspension Extension		08/06/22	258.78KB	Share
RAP	Voluntary Suspension Extension		06/06/22	258.86KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	02/06/22	668.62KB	Share
RAP	Trading Halt	PRICE SENSITIVE	31/05/22	678.4KB	Share
RAP	Notification of cessation of securities - RAP		19/05/22	21.78KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/04/22	324.36KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		21/04/22	88.16KB	Share
RAP	Proposed Acquisition of ResApp Health by Pfizer	PRICE SENSITIVE	11/04/22	850.05KB	Share
RAP	Investor Webinar		08/04/22	87.9KB	Share
RAP	Notification of cessation of securities - RAP		01/04/22	24.21KB	Share
RAP	Dartford and Gravesham NHS Trust to pilot ResAppDx	PRICE SENSITIVE	01/04/22	109.29KB	Share
RAP	COVID-19 Investor Presentation		22/03/22	4.72MB	Share
RAP	Reinstatement to Official Quotation	PRICE SENSITIVE	22/03/22	406.85KB	Share
RAP	ResApp announces positive results of COVID-19 screening test	PRICE SENSITIVE	22/03/22	142.1KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	21/03/22	548.98KB	Share
RAP	Trading Halt	PRICE SENSITIVE	17/03/22	241.41KB	Share
RAP	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	718.08KB	Share
RAP	Health Teams to launch ResAppDx on aged care platform	PRICE SENSITIVE	14/02/22	109KB	Share
RAP	Cough analysis patent granted in China	PRICE SENSITIVE	01/02/22	97.76KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/01/22	1.2MB	Share
RAP	Quarterly Results and Investor Conference Call Notification		27/01/22	59.65KB	Share
RAP	Further appointments to COVID-19 Scientific Advisory Board		27/01/22	108.02KB	Share
RAP	ResAppDx goes live with Doctors on Demand in Australia	PRICE SENSITIVE	24/01/22	99.78KB	Share
RAP	LOI signed with Homify to launch ResAppDx in the Philippines	PRICE SENSITIVE	20/01/22	105.46KB	Share
RAP	Publication highlights use of ResAppDx in COVID-19 clinic		17/01/22	108.91KB	Share
RAP	Notification regarding unquoted securities - RAP		13/01/22	28.2KB	Share
RAP	US COVID-19 study completes recruitment	PRICE SENSITIVE	10/01/22	84.23KB	Share
RAP	ResAppDx goes live with Alodokter in Indonesia	PRICE SENSITIVE	07/01/22	98.73KB	Share
RAP	Distribution agreement with Sanrai International	PRICE SENSITIVE	22/12/21	113.66KB	Share
RAP	Change of Registry Address		20/12/21	152.9KB	Share
RAP	ResApp receives $818,826 in R&D tax incentive refund	PRICE SENSITIVE	20/12/21	96.72KB	Share
RAP	ResApp Establishes COVID-19 Scientific Advisory Board		08/12/21	110KB	Share
RAP	Results of Annual General Meeting		30/11/21	248.48KB	Share
RAP	Annual General Meeting Presentation		30/11/21	2.49MB	Share
RAP	Letter to Shareholders		30/11/21	120.28KB	Share
RAP	ResApp receives regulatory approvals for cough counter	PRICE SENSITIVE	29/11/21	105.1KB	Share
RAP	ResApp completes COVID-19 study recruitment in India	PRICE SENSITIVE	23/11/21	106.18KB	Share
RAP	Publication on challenges of diagnosing respiratory disease		19/11/21	113.99KB	Share
RAP	ResApp secures contract with global pharmaceutical company	PRICE SENSITIVE	18/11/21	112.79KB	Share
RAP	Partnership with Carepath for in-home COPD monitoring		16/11/21	129.51KB	Share
RAP	IRB approval for US COVID-19 study modification	PRICE SENSITIVE	15/11/21	112.12KB	Share
RAP	Jobkeeper Payments Notice		09/11/21	218.21KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/10/21	311.74KB	Share
RAP	Quarterly Results and Investor Conference Call Notification		27/10/21	88.36KB	Share
RAP	Notice of Annual General Meeting		26/10/21	1.13MB	Share
RAP	Presentations at Conferences		26/10/21	4.22MB	Share
RAP	COVID-19 Clinical Studies Update	PRICE SENSITIVE	26/10/21	109.26KB	Share
RAP	Notice under ASX Listing Rule 3.13.1		12/10/21	176.26KB	Share
RAP	ResApp announces FDA 510(k) submission for SleepCheckRx	PRICE SENSITIVE	11/10/21	120.85KB	Share
RAP	Notification regarding unquoted securities - RAP		01/10/21	27.52KB	Share
RAP	Notification of cessation of securities - RAP		01/10/21	22.21KB	Share
RAP	Change of Share Registry		01/10/21	184.81KB	Share

RAP Removal from Official List
27/09/22		404.27KB	Share
RAP Scheme of Arrangement has been Implemented
26/09/22	PRICE SENSITIVE	55.41KB	Share
RAP Ceasing to be a substantial holder
20/09/22		58.53KB	Share
RAP Becoming a substantial holder
19/09/22		210.88KB	Share
RAP Notification of cessation of securities - RAP
16/09/22		31.71KB	Share
RAP Ceasing to be a substantial holder
16/09/22		80.15KB	Share
RAP Suspension from Official Quotation
15/09/22	PRICE SENSITIVE	591.98KB	Share
RAP Scheme of Arrangement becomes effective
15/09/22	PRICE SENSITIVE	130.98KB	Share
RAP Scheme of Arrangement - Court Approval
14/09/22	PRICE SENSITIVE	89.15KB	Share
RAP Becoming a substantial holder
08/09/22		175.85KB	Share
RAP Results of Scheme Meeting
07/09/22	PRICE SENSITIVE	185.86KB	Share
RAP Scheme Meeting - Chairman's Address & Presentation
07/09/22	PRICE SENSITIVE	2.89MB	Share
RAP Becoming a substantial holder
05/09/22		310.91KB	Share
RAP Appendix 4G
30/08/22		283.58KB	Share
RAP Corporate Governance Statement
30/08/22		114.04KB	Share
RAP Appendix 4E and Annual Report
30/08/22	PRICE SENSITIVE	2.18MB	Share
RAP Dispatch of Second Supplementary Scheme Booklet
29/08/22		124.05KB	Share
RAP Second Supplementary Scheme Booklet
25/08/22	PRICE SENSITIVE	918.11KB	Share
RAP Correction to ASX announcement
19/08/22		68.02KB	Share
RAP Adjournment of Scheme Meeting to a date to be determined
19/08/22	PRICE SENSITIVE	66.64KB	Share
RAP Best and Final Confirmation and Bridging Loan
16/08/22	PRICE SENSITIVE	489.09KB	Share
RAP Dispatch of Supplementary Scheme Booklet
08/08/22		135.55KB	Share
RAP Pfizer raises scheme consideration to A$0.208 per share
05/08/22	PRICE SENSITIVE	473.41KB	Share
RAP Correction to ASX announcement
03/08/22		87.02KB	Share
RAP Entry into amended and restated Scheme Implementation Deed
03/08/22	PRICE SENSITIVE	975.99KB	Share
RAP Investor Conference Call Notification
02/08/22		90.87KB	Share
RAP Quarterly Activities Report and Appendix 4C
27/07/22	PRICE SENSITIVE	1.2MB	Share
RAP Quarterly Results and Investor Conference Call Notification
25/07/22		88.58KB	Share
RAP Study shows efficacy of ResAppDx use with masks
22/07/22		101.02KB	Share
RAP Dispatch of Scheme Booklet
20/07/22		130.58KB	Share
RAP Clarification - Scheme Booklet registered with ASIC
20/07/22		127.96KB	Share
RAP Scheme Update - ACCC condition precedent satisfied
18/07/22	PRICE SENSITIVE	95.44KB	Share
RAP Scheme Booklet registered with ASIC
18/07/22	PRICE SENSITIVE	4.14MB	Share
RAP Results of First Court Hearing
15/07/22	PRICE SENSITIVE	131.07KB	Share
RAP Medgate Licence Agreement Clarification Announcement
11/07/22		87.61KB	Share
RAP Medgate extends licence agreement and plans to expand use
07/07/22	PRICE SENSITIVE	107.19KB	Share
RAP ResApp receives FDA 510(k) clearance for SleepCheckRx
06/07/22	PRICE SENSITIVE	106.06KB	Share
RAP Cough detection patent granted in Australia and Japan
05/07/22		88.02KB	Share
RAP Scheme Update
30/06/22		83.82KB	Share
RAP ResApp to present at Gold Coast Investment Showcase
23/06/22		87.84KB	Share
RAP Results from Data Confirmation Study
21/06/22	PRICE SENSITIVE	112.24KB	Share
RAP Trading Halt
20/06/22	PRICE SENSITIVE	675.51KB	Share
RAP Investor Webinar
17/06/22		87.97KB	Share
RAP Notification of cessation of securities - RAP
16/06/22		21.76KB	Share
RAP Application for quotation of securities - RAP
16/06/22		25KB	Share
RAP Notification of cessation of securities - RAP
14/06/22		22.12KB	Share
RAP Reinstatement to Official Quotation
14/06/22	PRICE SENSITIVE	410.87KB	Share
RAP Increased Scheme Consideration from Pfizer
14/06/22	PRICE SENSITIVE	833.75KB	Share
RAP Voluntary Suspension Extension
08/06/22		258.78KB	Share
RAP Voluntary Suspension Extension
06/06/22		258.86KB	Share
RAP Suspension from Official Quotation
02/06/22	PRICE SENSITIVE	668.62KB	Share
RAP Trading Halt
31/05/22	PRICE SENSITIVE	678.4KB	Share
RAP Notification of cessation of securities - RAP
19/05/22		21.78KB	Share
RAP Quarterly Activities Report and Appendix 4C
26/04/22	PRICE SENSITIVE	324.36KB	Share
RAP Quarterly Results and Investor Conference Call Notification
21/04/22		88.16KB	Share
RAP Proposed Acquisition of ResApp Health by Pfizer
11/04/22	PRICE SENSITIVE	850.05KB	Share
RAP Investor Webinar
08/04/22		87.9KB	Share
RAP Notification of cessation of securities - RAP
01/04/22		24.21KB	Share
RAP Dartford and Gravesham NHS Trust to pilot ResAppDx
01/04/22	PRICE SENSITIVE	109.29KB	Share
RAP COVID-19 Investor Presentation
22/03/22		4.72MB	Share
RAP Reinstatement to Official Quotation
22/03/22	PRICE SENSITIVE	406.85KB	Share
RAP ResApp announces positive results of COVID-19 screening test
22/03/22	PRICE SENSITIVE	142.1KB	Share
RAP Suspension from Official Quotation
21/03/22	PRICE SENSITIVE	548.98KB	Share
RAP Trading Halt
17/03/22	PRICE SENSITIVE	241.41KB	Share
RAP Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	718.08KB	Share
RAP Health Teams to launch ResAppDx on aged care platform
14/02/22	PRICE SENSITIVE	109KB	Share
RAP Cough analysis patent granted in China
01/02/22	PRICE SENSITIVE	97.76KB	Share
RAP Quarterly Activities Report and Appendix 4C
28/01/22	PRICE SENSITIVE	1.2MB	Share
RAP Quarterly Results and Investor Conference Call Notification
27/01/22		59.65KB	Share
RAP Further appointments to COVID-19 Scientific Advisory Board
27/01/22		108.02KB	Share
RAP ResAppDx goes live with Doctors on Demand in Australia
24/01/22	PRICE SENSITIVE	99.78KB	Share
RAP LOI signed with Homify to launch ResAppDx in the Philippines
20/01/22	PRICE SENSITIVE	105.46KB	Share
RAP Publication highlights use of ResAppDx in COVID-19 clinic
17/01/22		108.91KB	Share
RAP Notification regarding unquoted securities - RAP
13/01/22		28.2KB	Share
RAP US COVID-19 study completes recruitment
10/01/22	PRICE SENSITIVE	84.23KB	Share
RAP ResAppDx goes live with Alodokter in Indonesia
07/01/22	PRICE SENSITIVE	98.73KB	Share
RAP Distribution agreement with Sanrai International
22/12/21	PRICE SENSITIVE	113.66KB	Share
RAP Change of Registry Address
20/12/21		152.9KB	Share
RAP ResApp receives $818,826 in R&D tax incentive refund
20/12/21	PRICE SENSITIVE	96.72KB	Share
RAP ResApp Establishes COVID-19 Scientific Advisory Board
08/12/21		110KB	Share
RAP Results of Annual General Meeting
30/11/21		248.48KB	Share
RAP Annual General Meeting Presentation
30/11/21		2.49MB	Share
RAP Letter to Shareholders
30/11/21		120.28KB	Share
RAP ResApp receives regulatory approvals for cough counter
29/11/21	PRICE SENSITIVE	105.1KB	Share
RAP ResApp completes COVID-19 study recruitment in India
23/11/21	PRICE SENSITIVE	106.18KB	Share
RAP Publication on challenges of diagnosing respiratory disease
19/11/21		113.99KB	Share
RAP ResApp secures contract with global pharmaceutical company
18/11/21	PRICE SENSITIVE	112.79KB	Share
RAP Partnership with Carepath for in-home COPD monitoring
16/11/21		129.51KB	Share
RAP IRB approval for US COVID-19 study modification
15/11/21	PRICE SENSITIVE	112.12KB	Share
RAP Jobkeeper Payments Notice
09/11/21		218.21KB	Share
RAP Quarterly Activities Report and Appendix 4C
28/10/21	PRICE SENSITIVE	311.74KB	Share
RAP Quarterly Results and Investor Conference Call Notification
27/10/21		88.36KB	Share
RAP Notice of Annual General Meeting
26/10/21		1.13MB	Share
RAP Presentations at Conferences
26/10/21		4.22MB	Share
RAP COVID-19 Clinical Studies Update
26/10/21	PRICE SENSITIVE	109.26KB	Share
RAP Notice under ASX Listing Rule 3.13.1
12/10/21		176.26KB	Share
RAP ResApp announces FDA 510(k) submission for SleepCheckRx
11/10/21	PRICE SENSITIVE	120.85KB	Share
RAP Notification regarding unquoted securities - RAP
01/10/21		27.52KB	Share
RAP Notification of cessation of securities - RAP
01/10/21		22.21KB	Share
RAP Change of Share Registry
01/10/21		184.81KB	Share

REFRESH

1 2 3 4 5 6

RAPTOR RESOURCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available